查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426177

2024年全球輸血診斷市場報告

Blood Transfusion Diagnostics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

輸血診斷市場規模預計在未來幾年將快速成長。預計到 2028 年將以 8.1% 的複合年成長率 (CAGR) 成長至 60.4 億美元。預計未來一段時間的預期成長將受到幾個關鍵因素的推動。其中包括對精準醫療的需求不斷成長、加強輸血基礎設施的投資增加、對分子輸血診斷的需求不斷成長、新出現的感染疾病引起的擔憂以及對確保血液安全的日益關注等。

由於每年進行的手術數量增加，對輸血診斷的需求也增加。這些診斷對於在將血液輸給患者之前篩檢捐血的血液和預防潛在的感染疾病至關重要。據估計，每年進行 3.1 億例手術，輸血診斷的需求也隨著這些手術增加。

血液相關疾病極大地促進了輸血診斷市場的擴大。貧血、白血病和凝血疾病等疾病需要準確診斷，以便及早發現和安全管理。這些疾病的流行情況一目了然，2023年1月的統計顯示，急性骨髓性白血病新增感染人數約為59,610人，死亡人數為23,710人，新增感染人數約為2人。（AML）佔 380人。這種流行增加了對改進診斷的需求，以確保最佳的患者照護。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球輸血診斷市場的驅動與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023年全球輸血診斷市場規模表現與成長
  • 2023-2028、2033年全球輸血診斷市場規模及成長預測

第6章市場區隔

  • 全球輸血診斷市場，按類型、實際和預測細分，2018-2023、2023-2028、2033
  • 設備和套件
  • 試劑
  • 其他
  • 全球輸血診斷市場，依技術、效能和預測細分，2018-2023、2023-2028、2033
  • 西方墨點法
  • ELISA
  • 核酸擴增
  • 螢光測定
  • 快速測試
  • 全球輸血診斷市場，按應用、效能和預測細分，2018-2023、2023-2028、2033
  • 血型分類
  • 疾病篩檢
  • 全球輸血診斷市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷實驗室
  • 血庫
  • 血漿分餾公司

第 7 章 區域與國家分析

  • 全球輸血診斷市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球輸血診斷市場，依國家、績效及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 輸血診斷市場競爭形勢
  • 輸血診斷市場公司概況
    • BAG Health Care GmbH
    • Grifols SA
    • Bio-Rad .
    • Abbott Laboratories
    • Immucor Inc

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與潛力分析

第35章附錄

簡介目錄
Product Code: r13199

Blood transfusion diagnostics play a crucial role in conducting tests before the transfer of blood between donors and recipients, encompassing assessments like blood grouping and disease screening.

These diagnostics are primarily categorized into instruments and kits, along with reagents and other ancillary tools. Blood transfusion diagnostic kits are instrumental in collecting and safely transfusing blood, utilizing technologies like western blot, ELISA, nucleic acid amplification, fluorescence assays, and rapid testing. These technologies are employed across diverse applications, specifically in blood grouping and disease screening procedures. End-users of blood transfusion diagnostics span various sectors, including hospitals, diagnostic laboratories, blood banks, and companies engaged in plasma fractionation. These entities rely on these diagnostic tools to ensure the safe and accurate transfer of blood components between donors and recipients.

The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood transfusion diagnostics market size has grown rapidly in recent years. It will grow from $3.98 billion in 2023 to $4.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth observed in the historical period can be attributed to several key factors. These include the rising frequency of blood transfusions, the emergence of new pathogens necessitating stringent diagnostics, an aging population requiring more transfusions, a growing demand for swift and efficient blood transfusion diagnostics, the increasing prevalence of chronic diseases requiring transfusion support, and an overall rise in the demand for blood products. These elements collectively contributed to the growth and advancements in blood transfusion diagnostics during this period.

The blood transfusion diagnostics market size is expected to see rapidly grown in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. Anticipated growth in the upcoming period is expected to stem from several key factors. These include the increasing demand for precision medicine, heightened investments in enhancing blood transfusion infrastructure, a growing need for molecular blood transfusion diagnostics, concerns arising from emerging infectious diseases, and an amplified focus on ensuring blood safety.

The demand for blood transfusion diagnostics is on the rise, fueled by the increasing number of surgeries performed annually. These diagnostics are crucial in screening donated blood before transfusion to patients, preventing potential infectious diseases. With an estimated 310 million surgeries conducted each year, the necessity for blood transfusion diagnostics is growing in tandem with these procedures.

Blood-related diseases are contributing significantly to the expansion of the blood transfusion diagnostics market. Conditions like anemias, leukemia, and clotting disorders necessitate precise diagnostics for early detection and safe management. The prevalence of these diseases is evident, with statistics from January 2023 showing approximately 59,610 new cases and 23,710 deaths from leukemia, while acute myeloid leukemia (AML) accounted for around 20,380 new cases. This prevalence drives the need for improved diagnostics to ensure optimal patient care.

The inclination toward nucleic acid amplification testing (NAT) for blood safety and efficiency is growing due to its accuracy in detecting pathogens like bacteria and viruses. This testing method, detecting specific nucleic acids of pathogens in blood, tissue, or urine, offers high sensitivity and early identification of infectious diseases. XCRP Diagnostic Inc. and Luminex Corporations' agreement for the Xtreme Chain Reaction Nucleic Acid Amplification Technology exemplifies the industry's focus on advancing diagnostic capabilities through strategic partnerships.

Innovations in serological testing, such as the Immediate Spin Crossmatch (ISXM) test, are enhancing blood transfusion diagnostics. This test aids in identifying ABO blood type incompatibility between donor red blood cells and recipient serum/plasma. Ortho Clinical Diagnostics' launch of immediate spin crossmatch capabilities on the ORTHO VISION and ORTHO VISION MAX Analyzers in September 2021 underlines the industry's commitment to evolving diagnostic solutions for better donor-recipient matching in transfusions.

Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Quotient Limited, HologicInc., Roche Diagnostics, bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Gen-Probe, Proteomes Sciences PLC, Danaher Corporation, Immucor Inc., Becton Dickinson and Company, Quotient Biodiagnostics, Thermo Fisher Scientific, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

North America was the largest region in the blood transfusion diagnostics market in 2023. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Transfusion Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood transfusion diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood transfusion diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood transfusion diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Instruments and Kits; Reagents; Other Types
  • 2) By Technology: Western Blot; ELISA; Nucleic Acid Amplification; Fluorescence assay; Rapid Test
  • 3) By Application: Blood Grouping; Disease Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Blood Banks; Plasma Fractionation Companies
  • Companies Mentioned: BAG Health Care GmbH; Grifols S.A.; Bio-Rad LaboratoriesInc.; Abbott Laboratories; Immucor Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Transfusion Diagnostics Market Characteristics

3. Blood Transfusion Diagnostics Market Trends And Strategies

4. Blood Transfusion Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Blood Transfusion Diagnostics Market Size and Growth

  • 5.1. Global Blood Transfusion Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Blood Transfusion Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Blood Transfusion Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Blood Transfusion Diagnostics Market Segmentation

  • 6.1. Global Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments and Kits
  • Reagents
  • Other Types
  • 6.2. Global Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Western Blot
  • ELISA
  • Nucleic Acid Amplification
  • Fluorescence assay
  • Rapid Test
  • 6.3. Global Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Grouping
  • Disease Screening
  • 6.4. Global Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Plasma Fractionation Companies

7. Blood Transfusion Diagnostics Market Regional And Country Analysis

  • 7.1. Global Blood Transfusion Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Blood Transfusion Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Blood Transfusion Diagnostics Market

  • 8.1. Asia-Pacific Blood Transfusion Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Blood Transfusion Diagnostics Market

  • 9.1. China Blood Transfusion Diagnostics Market Overview
  • 9.2. China Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Blood Transfusion Diagnostics Market

  • 10.1. India Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Blood Transfusion Diagnostics Market

  • 11.1. Japan Blood Transfusion Diagnostics Market Overview
  • 11.2. Japan Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Blood Transfusion Diagnostics Market

  • 12.1. Australia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Blood Transfusion Diagnostics Market

  • 13.1. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Blood Transfusion Diagnostics Market

  • 14.1. South Korea Blood Transfusion Diagnostics Market Overview
  • 14.2. South Korea Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Blood Transfusion Diagnostics Market

  • 15.1. Western Europe Blood Transfusion Diagnostics Market Overview
  • 15.2. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Blood Transfusion Diagnostics Market

  • 16.1. UK Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Blood Transfusion Diagnostics Market

  • 17.1. Germany Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Blood Transfusion Diagnostics Market

  • 18.1. France Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Blood Transfusion Diagnostics Market

  • 19.1. Italy Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Blood Transfusion Diagnostics Market

  • 20.1. Spain Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Blood Transfusion Diagnostics Market

  • 21.1. Eastern Europe Blood Transfusion Diagnostics Market Overview
  • 21.2. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Blood Transfusion Diagnostics Market

  • 22.1. Russia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Blood Transfusion Diagnostics Market

  • 23.1. North America Blood Transfusion Diagnostics Market Overview
  • 23.2. North America Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Blood Transfusion Diagnostics Market

  • 24.1. USA Blood Transfusion Diagnostics Market Overview
  • 24.2. USA Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Blood Transfusion Diagnostics Market

  • 25.1. Canada Blood Transfusion Diagnostics Market Overview
  • 25.2. Canada Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Blood Transfusion Diagnostics Market

  • 26.1. South America Blood Transfusion Diagnostics Market Overview
  • 26.2. South America Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Blood Transfusion Diagnostics Market

  • 27.1. Brazil Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Blood Transfusion Diagnostics Market

  • 28.1. Middle East Blood Transfusion Diagnostics Market Overview
  • 28.2. Middle East Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Blood Transfusion Diagnostics Market

  • 29.1. Africa Blood Transfusion Diagnostics Market Overview
  • 29.2. Africa Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Blood Transfusion Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Blood Transfusion Diagnostics Market Competitive Landscape
  • 30.2. Blood Transfusion Diagnostics Market Company Profiles
    • 30.2.1. BAG Health Care GmbH
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Grifols S.A.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bio-Rad .
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Immucor Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Blood Transfusion Diagnostics Market Competitive Benchmarking

32. Global Blood Transfusion Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Blood Transfusion Diagnostics Market

34. Blood Transfusion Diagnostics Market Future Outlook and Potential Analysis

  • 34.1 Blood Transfusion Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Blood Transfusion Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Blood Transfusion Diagnostics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer